Cowen downgraded Akcea Therapeutics, Inc. (NASDAQ: AKCA) from Outperform to Market Perform.Analyst Eric Schmidt steps the sideline as effective management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE